In an attempt to develop anti-AIDS drugs, the compound isatin P-thiose
micarbazone has been subjected to systematic structural modifications.
The resulting synthesized thiosemicarbazone derivatives (TSCDs) were
examined for their ability to act as antiretrovirus agents in a model
system - 2M3/M cell system - consisting of B lymphocytes transformed b
y the v-abl oncogene and chronically infected with a retrovirus, the M
oloney leukemia virus (M-MuLV). The efficacy of the synthesized TSCDs
against retroviruses was determined by assaying the therapeutic index
(TI) values of the compounds. The results enabled the classification o
f TSCD groups based on the relationship between chemical structure and
antiretroviral activity. The compound N-allylisatin-beta':4'-diallylt
hiosemicarbazone showed the highest TI value and efficiently suppresse
d the chronic infection of M-MuLV in continuous long-term treatment.